Literature DB >> 1501568

Effect of iron supplementation on endurance capacity in iron-depleted female runners.

L A Klingshirn1, R R Pate, S P Bourque, J M Davis, R G Sargent.   

Abstract

The purpose of this investigation was to examine the effects of oral iron supplementation on endurance performance in initially iron-depleted, nonanemic female distance runners. Eighteen iron-depleted (serum ferritin less than 20 ng.ml-1, hemoglobin greater than or equal to 12 g.dl-1) women (22-39 yr) performed a VO2max test and an endurance run to exhaustion. Subjects were pair-matched on the basis of endurance time and then randomly assigned to an iron supplement or a placebo group. Following supplementation, the iron group had a significantly higher (P = 0.03) mean serum ferritin concentration (23.4 vs 15.7 ng.ml-1) and lower (P = 0.04) mean total iron-binding capacity than the placebo group. Both groups increased their time to exhaustion (25.5% and 22.2% for the iron and placebo groups, respectively) but were not significantly different (P = 0.72) from each other. There were also no differences (P greater than 0.05) between the groups with respect to lactate concentrations and physiological measures taken during the two exercise tests. The results of this study suggest that 8 wk of oral iron supplementation improves iron status in iron-depleted female distance runners, but does not enhance endurance capacity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1501568

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  13 in total

1.  Do high blood hepcidin concentrations contribute to low ferritin levels in young tennis players at the end of tournament season?

Authors:  Ewa Ziemann; Katarzyna Kasprowicz; Anna Kasperska; Agnieszka Zembroń-Lacny; Jedrzej Antosiewicz; Radoslaw Laskowski
Journal:  J Sports Sci Med       Date:  2013-06-01       Impact factor: 2.988

2.  Evaluation of iron metabolism indices and their relation with physical work capacity in athletes.

Authors:  S O Karamizrak; C Işlegen; S R Varol; Y Taşkiran; C Yaman; I Mutaf; N Akgün
Journal:  Br J Sports Med       Date:  1996-03       Impact factor: 13.800

Review 3.  Anaemia and iron deficiency in athletes. Practical recommendations for treatment.

Authors:  J C Chatard; I Mujika; C Guy; J R Lacour
Journal:  Sports Med       Date:  1999-04       Impact factor: 11.136

Review 4.  Dietary Iron and the Elite Dancer.

Authors:  Caitlin Attwell; Cory Dugan; Alannah K A McKay; Joanna Nicholas; Luke Hopper; Peter Peeling
Journal:  Nutrients       Date:  2022-05-05       Impact factor: 6.706

Review 5.  Iron supplementation in athletes. Current recommendations.

Authors:  P Nielsen; D Nachtigall
Journal:  Sports Med       Date:  1998-10       Impact factor: 11.136

Review 6.  Athletic induced iron deficiency: new insights into the role of inflammation, cytokines and hormones.

Authors:  Peter Peeling; Brian Dawson; Carmel Goodman; Grant Landers; Debbie Trinder
Journal:  Eur J Appl Physiol       Date:  2008-07       Impact factor: 3.078

Review 7.  Iron, meat and health.

Authors:  Catherine Geissler; Mamta Singh
Journal:  Nutrients       Date:  2011-02-28       Impact factor: 5.717

8.  Dietary iron intervention using a staple food product for improvement of iron status in female runners.

Authors:  Ieva Alaunyte; Valentina Stojceska; Andrew Plunkett; Emma Derbyshire
Journal:  J Int Soc Sports Nutr       Date:  2014-10-18       Impact factor: 5.150

9.  Association between preoperative haemoglobin concentration and cardiopulmonary exercise variables: a multicentre study.

Authors:  James M Otto; Alasdair F O'Doherty; Philip J Hennis; Jackie A Cooper; Michael Pw Grocott; Chris Snowdon; John B Carlisle; Michael Swart; Toby Richards; Hugh E Montgomery
Journal:  Perioper Med (Lond)       Date:  2013-09-13

10.  Four weeks of IV iron supplementation reduces perceived fatigue and mood disturbance in distance runners.

Authors:  Amy Woods; Laura A Garvican-Lewis; Philo U Saunders; Greg Lovell; David Hughes; Ruth Fazakerley; Bev Anderson; Christopher J Gore; Kevin G Thompson
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.